Intervention Review

Mu-opioid antagonists for opioid-induced bowel dysfunction

  1. Ewan D McNicol1,*,
  2. David Boyce2,
  3. Roman Schumann3,
  4. Daniel B Carr4

Editorial Group: Cochrane Pain, Palliative and Supportive Care Group

Published Online: 23 APR 2008

Assessed as up-to-date: 7 FEB 2008

DOI: 10.1002/14651858.CD006332.pub2


How to Cite

McNicol ED, Boyce D, Schumann R, Carr DB. Mu-opioid antagonists for opioid-induced bowel dysfunction. Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No.: CD006332. DOI: 10.1002/14651858.CD006332.pub2.

Author Information

  1. 1

    Tufts Medical Center, Pharmacy and Anesthesiology, Boston, MA, USA

  2. 2

    Tufts University School of Medicine, Boston, MA, USA

  3. 3

    Tufts Medical Center, Department of Anesthesiology, Boston, Massachusetts, USA

  4. 4

    Tufts Medical Center, Department of Anesthesia, Boston, USA

*Ewan D McNicol, Pharmacy and Anesthesiology, Tufts Medical Center, Box #420, 800 Washington Street, Boston, MA, 02111, USA. ewanmcnicol@comcast.net.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 23 APR 2008

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Chih-Peng Tu, Chung-Hsin Tsai, Chia-Chi Tsai, Tung-Sun Huang, Shih-Ping Cheng, Tsang-Pai Liu, Postoperative Ileus in the Elderly, International Journal of Gerontology, 2014, 8, 1, 1

    CrossRef

  2. 2
    D. Fletcher, Farmacologia degli oppioidi, EMC - Anestesia-Rianimazione, 2011, 16, 2, 1

    CrossRef

  3. 3
    S. Lawrence Librach, Palliative Care, 2011,

    CrossRef

  4. 4
    S. Lawrence Librach, Maryse Bouvette, Carlo De Angelis, Justine Farley, Doreen Oneschuk, José Luis Pereira, Ann Syme, Consensus Recommendations for the Management of Constipation in Patients with Advanced, Progressive Illness, Journal of Pain and Symptom Management, 2010, 40, 5, 761

    CrossRef

  5. 5
    Siddharth Singh, Satish S.C. Rao, Pharmacologic Management of Chronic Constipation, Gastroenterology Clinics of North America, 2010, 39, 3, 509

    CrossRef

  6. 6
    David R. P. Guay, <b>Methylnaltrexone Methobromide: The First Peripherally Active, Centrally Inactive Opioid Receptor-Antagonist Clinical Review</b>, The Consultant Pharmacist, 2009, 24, 3, 210

    CrossRef

  7. 7
    Barbara J. Pleuvry, Gastric disorders: modifications of gastric content, antacids and drugs influencing gastric secretions and motility, Anaesthesia & Intensive Care Medicine, 2009, 10, 7, 351

    CrossRef

  8. 8
    Gerhild Becker, Hubert E Blum, Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus, The Lancet, 2009, 373, 9670, 1198

    CrossRef

  9. 9
    Barbara Reville, David Axelrod, Rebecca Maury, Palliative Care for the Cancer Patient, Primary Care: Clinics in Office Practice, 2009, 36, 4, 781

    CrossRef

  10. 10
    Recommandations pour la prévention et le traitement de la constipation induite par les opioïdes chez le patient relevant de soins palliatifs, Médecine Palliative : Soins de Support - Accompagnement - Éthique, 2009, 8, S5

    CrossRef

  11. 11
    Roger Chou, Jane C. Ballantyne, Gilbert J. Fanciullo, Perry G. Fine, Christine Miaskowski, Research Gaps on Use of Opioids for Chronic Noncancer Pain: Findings From a Review of the Evidence for an American Pain Society and American Academy of Pain Medicine Clinical Practice Guideline, The Journal of Pain, 2009, 10, 2, 147

    CrossRef

  12. 12
    Bridget Candy, Louise Jones, Margaret Lynn Goodman, Robyn Drake, Adrian Tookman, Laxatives or methylnaltrexone for the management of constipation in palliative care patients, The Cochrane Library,